FINWIRES · TerminalLIVE
FINWIRES

Yankuang Energy to Renew Related-Party Deals

By

Yankuang Energy (HKG:1171, SHA:600188) agreed to renew its related-party deals with its controlling shareholder, Shandong Energy Group, until 2028, according to a Shanghai bourse disclosure on Wednesday.

The transactions include the supply of materials and equipment, labor and services, the management of insurance funds, leasing deals and financial services.

The annual threshold for this year's transactions was increased from the last year.

The coal mining company's shares jumped 5% at the close.

Related Articles

Asia

IndusInd Bank Denies Receiving Any Whistleblower Complaint Cited in Media Report

IndusInd Bank (NSE:INDUSINDBK, BOM:532187) said it has not received any communication from government or regulatory authorities regarding a whistleblower complaint mentioned in recent media reports, according to a Wednesday filing on Indian bourses.The clarification came after a media report suggested that a whistleblower complaint had been sent to the Prime Minister's Office and multiple regulators, including the Reserve Bank of India, the Serious Fraud Investigation Office, and the National Financial Reporting Authority. The report alleged insider trading, governance lapses, and issues in forensic and audit reviews following a 20-billion-rupee derivatives discrepancy.The bank said it has previously examined similar issues and has taken appropriate actions in line with its internal policies and regulatory requirements. It added that certain matters have also been proactively reported to relevant authorities and it continues to cooperate with regulators.

$BOM:532187$NSE:INDUSINDBK
Asia

China's Drug Regulator Accepts Marketing Application of Humanwell's Subsidiary for Landiolol Hydrochloride

China's National Medical Products Administration accepted the marketing application of Humanwell Healthcare's (SHA:600079) subsidiary, Yichang Humanwell Pharmaceutical, for landiolol hydrochloride for injection, according to a Shanghai bourse filing on Thursday.The drug is used for the treatment of tachyarrhythmias in patients with heart failure or during surgery.The pharmaceutical company invested 9.5 million yuan into the research and development of the drug.

$SHA:600079
Asia

Market Chatter: Malaysia Ensures Stable Gas Supply Despite Global Shortage

Malaysia's gas supply remains stable, with most electricity generation still backed by domestic sources, while the government continues to monitor the energy sector amid global uncertainties, The Star reported Thursday, citing Science, Technology and Innovation Minister Datuk Chang Lih Kang.Around 80% of the country's power generation is supported by local resources, limiting exposure to external supply risks. Currently, the supply conditions are comfortable and do not raise any immediate concerns, according to the report.Separately, Gas Malaysia (KLSE:GASMSIA) chief executive Azli Mohamed said the industry is not experiencing any gas shortages. He noted that supplies are primarily sourced from domestic fields and Australia, with only minimal dependence on the Middle East. However, he cautioned thathigher logistics costs and supply chain disruptions could still emerge, The Star said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^KLSE$KLSE:GASMSIA